-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Protagenic Therapeutics, Inc.\new quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
- Protagenic Therapeutics, Inc.\new Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.61M, a 32.8% decline year-over-year.
- Protagenic Therapeutics, Inc.\new Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$6.4M, a 85.4% decline year-over-year.
- Protagenic Therapeutics, Inc.\new annual Net Income (Loss) Attributable to Parent for 2023 was -$5M, a 40.6% decline from 2022.
- Protagenic Therapeutics, Inc.\new annual Net Income (Loss) Attributable to Parent for 2022 was -$3.56M, a 21.4% increase from 2021.
- Protagenic Therapeutics, Inc.\new annual Net Income (Loss) Attributable to Parent for 2021 was -$4.52M, a 77.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)